The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy

Author:

Nagaoki Yuko1ORCID,Imamura Michio12,Nishida Yuno1,Daijo Kana1,Teraoka Yuji1,Honda Fumi1,Nakamura Yuki1,Morio Kei1,Fujino Hatsue12,Nakahara Takashi12,Kawaoka Tomokazu12,Tsuge Masataka123,Hiramatsu Akira12,Kawakami Yoshiiku12,Miki Daiki24,Hiyama Yuichi5,Ochi Hidenori124,Chayama Kazuaki124ORCID,Aikata Hiroshi12

Affiliation:

1. Department of Gastroenterology and Metabolism; Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University; Hiroshima Japan

2. Liver Research Project Center, Hiroshima University; Hiroshima Japan

3. Natural Science Center for Basic Research and Development, Hiroshima University; Hiroshima Japan

4. Laboratory for Digestive Diseases, RIKEN Center for Integrative Medical Sciences; Hiroshima Japan

5. Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences; Hiroshima University

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Virology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3